Fung-Kee-Fung M - Search Results

1

The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.

Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE. Reade CJ, et al. J Obstet Gynaecol Can. 2014 Feb;36(2):133-140. doi: 10.1016/S1701-2163(15)30659-9. J Obstet Gynaecol Can. 2014. PMID: 24518912 Review.

2

Early ovarian cancer: what is the staging impact of retroperitoneal node sampling?

Faught W, Le T, Fung Kee Fung M, Krepart G, Lotocki R, Heywood M. Faught W, et al. J Obstet Gynaecol Can. 2003 Jan;25(1):18-21. doi: 10.1016/s1701-2163(16)31078-7. J Obstet Gynaecol Can. 2003. PMID: 12548321

3

Systematic review of management options for women with a hereditary predisposition to ovarian cancer.

Rosen B, Kwon J, Fung Kee Fung M, Gagliardi A, Chambers A; Cancer Care Ontario's Practice Guidelines Initiative Gynecology Cancer Disease Site Group. Rosen B, et al. Gynecol Oncol. 2004 May;93(2):280-6. doi: 10.1016/j.ygyno.2004.02.013. Gynecol Oncol. 2004. PMID: 15099934 Review.

4

Ontario cervical cancer screening clinical practice guidelines.

Meg McLachlin C, Mai V, Murphy J, Fung-Kee-Fung M, Chambers A, Oliver TK; Cervical Screening Guidelines Development Committee of the Ontario Cervical Screening Program and the Gynecology Cancer Disease Site Group of Cancer Care Ontario. Meg McLachlin C, et al. J Obstet Gynaecol Can. 2007 Apr;29(4):344-353. doi: 10.1016/S1701-2163(16)32441-0. J Obstet Gynaecol Can. 2007. PMID: 17475128 Review.

5

Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer.

Le T, Faught W, Hopkins L, Fung-Kee-Fung M. Le T, et al. J Obstet Gynaecol Can. 2008 Aug;30(8):665-670. doi: 10.1016/S1701-2163(16)32914-0. J Obstet Gynaecol Can. 2008. PMID: 18786288

6

Variations in ultrasound reporting on patients referred for investigation of ovarian masses.

Le T, Fayadh RA, Menard C, Hicks-Boucher W, Faught W, Hopkins L, Fung-Kee-Fung M. Le T, et al. J Obstet Gynaecol Can. 2008 Oct;30(10):902-906. doi: 10.1016/S1701-2163(16)32970-X. J Obstet Gynaecol Can. 2008. PMID: 19038074

7

Can surgical debulking reverse platinum resistance in patients with metastatic epithelial ovarian cancer?

Le T, Faught W, Hopkins L, Fung-Kee-Fung M. Le T, et al. J Obstet Gynaecol Can. 2009 Jan;31(1):42-7. doi: 10.1016/s1701-2163(16)34052-x. J Obstet Gynaecol Can. 2009. PMID: 19208282

8

The significance of duration of chemotherapy interruptions due to interval surgery in ovarian cancer patients treated with neoadjuvant chemotherapy.

Le T, Fathi KA, Hopkins L, Faught W, Fung-Kee-Fung M. Le T, et al. J Obstet Gynaecol Can. 2009 Feb;31(2):161-6. doi: 10.1016/s1701-2163(16)34101-9. J Obstet Gynaecol Can. 2009. PMID: 19327216

9

Laparoscopic surgery for endometrial cancer: a review.

Hauspy J, Jiménez W, Rosen B, Gotlieb WH, Fung-Kee-Fung M, Plante M. Hauspy J, et al. J Obstet Gynaecol Can. 2010 Jun;32(6):570-579. doi: 10.1016/S1701-2163(16)34526-1. J Obstet Gynaecol Can. 2010. PMID: 20569538 Review.

10

Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists.

Reade CJ, Finlayson S, McAlpine J, Tone AA, Fung-Kee-Fung M, Ferguson SE. Reade CJ, et al. J Obstet Gynaecol Can. 2013 Jul;35(7):627-634. doi: 10.1016/S1701-2163(15)30894-X. J Obstet Gynaecol Can. 2013. PMID: 23876640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page